EQ-5D Visual Analog Scale and Utility Index Values in Individuals with Diabetes and at Risk for Diabetes: Findings from the Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes (SHIELD)
Overview
Authors
Affiliations
Background: The EQ-5D was used to compare burden experienced by respondents with diabetes and those at risk for diabetes.
Methods: A survey including the EQ-5D was mailed to individuals with self-reported diabetes, as well as those without diabetes but with the following risk factors (RFs): (1) abdominal obesity, (2) body mass index > or = 28 kg/m2, (3) dyslipidemia, (4) hypertension, and (5) cardiovascular disease. Non-diabetes respondents were combined into 0-2 RFs and 3-5 RFs. Mean EQ-5D scores were compared across groups using analysis of variance. Multivariable linear regression modeling identified factors affecting respondents' EQ-5D scores.
Results: Complete responses were available from >75% of each cohort. Mean EQ-5D index scores were significantly lower for respondents with type 2 diabetes and 3-5 RFs (0.778 and 0.792, respectively) than for those with 0-2 RFs (0.870, p < 0.001 for each); score for respondents with type 2 diabetes was also significantly lower than for those with 3-5 RFs (p < 0.001). Similar patterns were seen for visual analog scale (VAS). For both VAS and index scores, after adjusting for other characteristics, respondents reported decreasing EQ-5D scores as status moved from low to high risk (-6.49 for VAS score and -0.045 for index score) to a diagnosis of type 2 diabetes (-9.75 for VAS score and -0.054 for index score; p < 0.001 vs. 0-2 RFs for all).
Conclusion: High-risk and type 2 diabetes groups had similar EQ-5D scores, and both were substantially lower than in low-risk respondents.
Silva A, Martins A, Andias R, Nery E, Silva T, Ribeiro O Internet Interv. 2024; 38:100766.
PMID: 39280041 PMC: 11393595. DOI: 10.1016/j.invent.2024.100766.
Wang Y, Xu Y, Shan H, Pan H, Chen J, Yang J Health Qual Life Outcomes. 2024; 22(1):74.
PMID: 39244536 PMC: 11380328. DOI: 10.1186/s12955-024-02288-1.
Langabeer J, Vega F, Cardenas-Turanzas M, Cohen A, Lalani K, Champagne-Langabeer T Behav Sci (Basel). 2024; 14(5).
PMID: 38785885 PMC: 11117791. DOI: 10.3390/bs14050394.
Health-Related Quality of Life Assessment in Older Patients with Type 1 and Type 2 Diabetes.
Volcansek S, Lunder M, Janez A Healthcare (Basel). 2023; 11(15).
PMID: 37570394 PMC: 10418676. DOI: 10.3390/healthcare11152154.
Girardin F, Nicolet A, Bestard O, Lefaucheur C, Budde K, Halleck F Front Pharmacol. 2023; 14:1040584.
PMID: 37180729 PMC: 10174308. DOI: 10.3389/fphar.2023.1040584.